Stents Efficacious Alternative To Bypass In Multivessel Disease - ARTS Trial
This article was originally published in The Gray Sheet
Executive Summary
Coronary stents can save an estimated $4,500 in per-procedure, in-hospital costs over bypass surgery and are an efficacious alternative for patients with multivessel coronary disease, according to one-year follow-up results of the Arterial Revascularization Therapy Study (ARTS).